Comparison of efficacy and safety between carboplatin-etoposide and cisplatin-etoposide combination therapy in patients with advanced neuroendocrine carcinoma, retrospective study

CONCLUSION: The efficacy of CE and PE in patients with NEC is comparable. However, the incidence of renal dysfunction was found to be significantly higher in the PE group than in the CE group.PMID:37903486 | DOI:10.1159/000534747

Source: Oncology - October 30, 2023 Category: Cancer & Oncology Authors: Hiroo Imai Ken Saijo Yoshifumi Kawamura Shuto Kodera Keigo Komine Tomoyuki Iwasaki Noriko Takenaga Yuki Kasahara Kota Ouchi Hidekazu Shirota Masanobu Takahashi Chikashi Ishioka Source Type: research